A fatal side effect of piperacillin/tazobactam use: a case report.
Öz
Anahtar Kelimeler
Destekleyen Kurum
Kaynakça
- :1. Goldenberg I, Moss AJ, Zareba W. QT interval: how to measure it and what is "normal". J Cardiovasc Electrophysiol. 2006;17(3):333-336. doi:10.1111/j.1540-8167.2006.00408.x
- 2. Antzelevitch C, Shimizu W. Cellular mechanisms underlying the long QT syndrome. Curr Opin Cardiol. 2002;17(1):43-51. doi:10.1097/00001573-200201000-00007
- 3. Woosley RL. QT Drug Lists by Risk Groups. AZ: Arizona Center for Research and Education on Therapeutics. Published 2009. Accessed September 1, 2021. http:// www.azcert.org/medical-pros/drug-lists/drug-lists.cfm
- 4. Katchman AN, Koerner J, Tosaka T, Woosley RL, Ebert SN. Comparative evaluation of HERG currents and QT intervals following challenge with suspected torsadogenic and nontorsadogenic drugs. J Pharmacol Exp Ther. 2006;316(3):1098-1106. doi:10.1124/jpet.105.093393
- 5. Poluzzi E, Raschi E, Motola D, Moretti U, De Ponti F. Antimicrobials and the risk of torsades de pointes: the contribution from data mining of the US FDA Adverse Event Reporting System. Drug Saf. 2010;33(4):303-314. doi:10.2165/11531850-000000000-00000
- 6. Panduranga P, Al-Mukhaini M, Rajarao MP. Multi-factorial causes of torsade de pointes in a hospitalised surgical patient. Sultan Qaboos Univ Med J. 2013;13(1):152-155. doi:10.12816/0003211
- 7. Piperacillin and tazobactam: Drug information. Published December 6, 2020. Accessed semtember 1, 2021. . https://www.uptodate.com/contents/piperacillin-and-tazobactam-drug-information search=piperacillin%20tazobactam&source=panel_search_result&selectedTitle=1~104&usage_type=panel&kp_tab=drug_general&display_rank=1#F210382
Ayrıntılar
Birincil Dil
İngilizce
Konular
Yoğun Bakım
Bölüm
Olgu Sunumu
Yazarlar
Murat Duyan
*
0000-0002-6420-3259
Türkiye
Serhat Günlü
0000-0003-4346-0085
Türkiye
Ali Sarıdaş
0000-0002-2725-6001
Türkiye
Basar Cander
0000-0002-3308-5843
Türkiye
Yıldızhan Solaç
0000-0002-2040-4569
Türkiye
Yayımlanma Tarihi
28 Aralık 2021
Gönderilme Tarihi
8 Eylül 2021
Kabul Tarihi
8 Kasım 2021
Yayımlandığı Sayı
Yıl 2021 Cilt: 3 Sayı: 3